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The populations most sensitive to lead expo-
sure from various sources are pregnant women
and young children (National Research
Council 1993). Ongoing lead exposure not
only directly affects health, but also allows the
accumulation of lead in tissues such as bone.
During pregnancy, the mobilization of bone
lead increases, apparently as the bone is
resorbed to produce the fetal skeleton (Franklin
et al. 1997; Gulson et al. 1997a, 1998b;
Manton 1985). Previous studies using only
lead concentrations for a limited number of
samples (usually three to ﬁve) generally showed
an increase in blood lead levels during the
third trimester, which was attributed to
increased bone resorption to meet the calcium
requirements of the developing fetus (Hertz-
Picciotto et al. 2000; Lagerkvist et al. 1996;
Rothenberg et al. 1994; Schell et al. 2000,
2003; Schumacher et al. 1996; Sowers et al.
2002; West et al. 1994).
Recent studies, especially those employing
precision stable lead isotope methods, have
conﬁrmed the early work of Manton (1985)
and demonstrated that extra lead is released
from the maternal skeleton during pregnancy
and lactation in cynomolgus monkeys (Franklin
et al. 1997; O’Flaherty et al. 1998) and in
humans (Gulson et al. 1997a, 1998b, 2003;
Manton et al. 2003). Furthermore, these
studies showed that the lead is transferred to
the infant.
Because recent evidence suggests that
there are detrimental neurologic effects on
young children whose blood lead levels are
< 10 µg/dL (Canfield et al. 2003; Lanphear
et al. 2000), it is critical to minimize the
exposure of the developing fetus and the new-
born infant, especially lead from bone.
Results of several cross-sectional studies
have indicated that increased levels of calcium
during pregnancy have a protective effect,
reducing the amount of lead released from
bones (Farias et al. 1996; Hernandez-Avila
et al. 1996). Calcium carbonate supplementa-
tion of 1,200 mg elemental calcium/day gave
a modest reduction of 16% in blood lead lev-
els among lactating women with relatively
high bone lead burden (Hernandez-Avila et
al. 2003). In our longitudinal study of lead
mobilization from bone during pregnancy
and for 6 months postpartum, we found that
both newly arrived migrants to Australia and
multigenerational Australian subjects con-
sumed very low amounts of calcium in their
diets. Estimations were based on quarterly 6-
day duplicate diets and averaged about
400–600 mg calcium/day (Gulson et al.
2001), less than half the intakes recom-
mended by the National Institutes of Health
(1994).
Two of the migrant subjects who con-
sumed calcium supplements showed lower
amounts of lead mobilized from their skeleton
compared with the others on low calcium
intakes. In light of this ﬁnding and those of the
previous studies mentioned above, we under-
took a longitudinal investigation in which sub-
jects were provided with calcium supplements
during pregnancy and for 6 months post-
partum. Our hypothesis was that if calcium
supplementation is effective in reducing the
mobilization of lead from the maternal skele-
ton, then there should be little or no change in
blood lead or isotopic ratios during pregnancy
and postpartum.
Materials and Methods
We employed the protocols refined during
previous investigations (Gulson et al. 1995,
1997a, 1998b).
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Pregnancy and lactation are times of physiologic stress during which bone turnover is accelerated.
Previous studies have demonstrated that there is increased mobilization of lead from the maternal
skeleton at this time and that calcium supplementation may have a protective effect. Ten immigrants
to Australia were provided with either calcium carbonate or a complex calcium supplement
(~ 1 g/day) during pregnancy and for 6 months postpartum. Two immigrant subjects who did not
conceive acted as controls. Sampling involved monthly venous blood samples throughout pregnancy
and every 2 months postpartum, and quarterly environmental samples and 6-day duplicate diets. The
geometric mean blood lead at the time of ﬁrst sampling was 2.4 µg/dL (range, 1.4–6.5). Increases in
blood lead during the third trimester, corrected for hematocrit, compared with the minimum value
observed, varied from 10 to 50%, with a geometric mean of 25%. The increases generally occurred at
6–8 months gestation, in contrast with that found for a previous cohort, characterized by very low cal-
cium intakes, where the increases occurred at 3–6 months. Large increases in blood lead concentration
were found during the postpartum period compared with those during pregnancy; blood lead concen-
trations increased by between 30 and 95% (geometric mean 65%; n = 8) from the minimum value
observed during late pregnancy. From late pregnancy through postpartum, there were signiﬁcant
increases in the lead isotopic ratios from the minimum value observed during late pregnancy for 3 of
8 subjects (p < 0.01). The observed changes are considered to reﬂect increases in mobilization of lead
from the skeleton despite calcium supplementation. The identical isotopic ratios in maternal and cord
blood provide further conﬁrmation of placental transfer of lead. The extra ﬂux released from bone
during late pregnancy and postpartum varies from 50 to 380 µg lead (geometric mean, 145 µg lead)
compared with 330 µg lead in the previous cohort. For subjects replete in calcium, the delay in
increase in blood lead and halving of the extra ﬂux released from bone during late pregnancy and post-
partum may provide less lead exposure to the developing fetus and newly born infant. Nevertheless, as
shown in several other studies on calcium relationships with bone turnover, calcium supplementation
appears to provide limited beneﬁt for lead toxicity during lactation. Key words: blood, bone remodel-
ing, calcium supplementation, lead, lead isotopes, postpartum, pregnancy. Environ Health Perspect
112:1499–1507 (2004). doi:10.1289/ehp.6548 available via http://dx.doi.org/ [Online 27 July 2004]Subjects. Participants were female immi-
grants to Australia who were of child-bearing
age (19–32 years) and whose skeletal lead
isotopic composition, based on our previous
investigations and an initial blood sample, was
different from that in their current environ-
ment. In essence, the lead isotopic composi-
tion or “fingerprint” in multigenerational
Australian residents is different from that in
subjects from most other countries, although
these differences are reducing over the past
decade because of globalization (Gulson 2000;
Gulson et al. 2001). Hence, by monitoring
migrant subjects who conceive after arrival in
Australia, it is possible to detect changes in
isotopic composition and lead during preg-
nancy and the postpartum period arising from
increased mobilization of skeletal lead. The
approach of using subjects whose skeletal lead
was different from that in their current envi-
ronment to determine exchange phenomenon
was first explored by Manton (1977, 1985)
and later reiterated by Rabinowitz (1991).
Subjects were recruited by networking
through our previous cohort study (Gulston
et al. 1998b), from English language classes,
and via limited advertising in ethnic news-
papers. Compared with the previous cohort,
there are some differences in demographics of
the subjects in our present study. For example,
in the previous cohort, most subjects were
from Eastern Bloc countries, such as the for-
mer Soviet Union and former Yugoslavia.
With changing migration patterns to Australia,
subjects in the present study were from South
Asia and the Middle East (Table 1). One sub-
ject (subject no. 1226) was approximately
4 months pregnant when recruited but was
retained because our previous investigations of
people from other countries showed that, in all
cases, their isotopic compositions were differ-
ent from that of long-term Australians. Subject
1208 miscarried during the first trimester of
her ﬁrst pregnancy. Subject 1231 returned to
China immediately after the birth of her child,
so no postpartum results are available. Two
nonpregnant control subjects were matched
mainly on country of origin as other parame-
ters such as age, parity, and blood lead con-
centration were found not to be critical in
previous studies (Gulson et al. 1997a, 1998b).
Signed consent forms were obtained from
each volunteer. This consent form had been
reviewed and approved by the ethics commit-
tees of the Central Sydney Area Health Service,
Western Sydney Area Health Service, and
Macquarie University. As part of the entry
requirements into Australia, all subjects were
declared medically ﬁt.
Sampling and analysis. Blood and urine
samples were obtained monthly during preg-
nancy and the postpregnancy period for
≥ 6 months. The urine samples were collected
to back up the blood samples in case isotopic
data could not be obtained from the blood
samples. Environmental samples of 6-day
duplicate diet, drinking water, house dust,
gasoline, and ambient air were collected quar-
terly. High-precision lead isotope ratios and
lead concentrations were obtained by thermal
ionization mass spectrometry. Details of ana-
lytical methods have been published previ-
ously (Gulson et al. 1995, 1997a, 1998b).
As in our previous reports (Gulson et al.
1995, 1997a, 1998b), our data are expressed as
206Pb:204Pb ratios for ease of identifying and
illustrating changes, especially for readers with
limited experience in isotopic methods and for
whom signiﬁcant differences in the third deci-
mal place of a ratio of, say 0.900, may seem
unrealistic. Although Manton and colleagues
(2003) express results as 206Pb:207Pb, direct
comparisons of variations can be made between
our data because 206Pb is the numerator in both
ratios. For the statistical analyses, both the
measured 207Pb:206Pb and 206Pb:204Pb ratios
were treated.
Hematocrit was measured in blood sam-
ples and creatinine in the urine samples using
standard methods.
Calcium supplements. Because it was not
viable to produce a custom supplement for
this study, commercially available Australian
calcium supplements, which are typically
made from overseas components, were admin-
istered to the subjects. Details of the supple-
ments are given in Table 2. The supplements
were those with the lowest concentrations of
lead and were evaluated as suitable in the
following investigation.
Approximately 6 months into the present
study, we investigated the impact on blood lead
of the calcium supplements to be provided to
the subjects. This was necessary to satisfy our-
selves that we were not “poisoning” the sub-
jects and their developing fetuses because there
had been much recent publicity about the
potential toxicity of supplements (Boulos and
Smolinski 1988; Bourgoin et al. 1993; Capar
and Gould 1979; Rogan et al. 1999; Scelfo
and Flegal 2000). This publicity occurred
despite earlier work from the 1980s indicating
that calcium (plus phosphorus) inhibited the
uptake of lead from the gastrointestinal tract.
Furthermore, Rogan et al. (1999) discovered
that vitamin supplements used in the multi-
center lead trial were contaminated with lead.
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Table 1. Subject information.
Subject Country of Time to conception No. of Age Calcium Average compliance Initial Pb Sex of
identiﬁer origin (months) after arrival children (years) supplement (%) during pregnancy (µg/dL) newborn Breast-feeding
1204 Bulgaria 13 1 31 Carbonate 68 4.0 M > 6 months
1207a Croatia NA 1 26 NA NA 1.0 NA NA
1208b Bosnia 34 1 23 Carbonate 73 1.9 M/F 0
1211c Bangladesh 8 1 25 Carbonate 95 1.6 M 3 months
1212c Turkey 20 1 31 Carbonate 86 (1st 2 months) 2.4 F > 6 months
1213 Lebanon 4 0 32 Complex 71 (1st 6 months) 2.9 M < 2 weeks
1214 Turkey 14 0 25 Complex 52 1.8 F 0
1224a Bulgaria NA 0 31 NA NA 2.4 NA NA
1225c Pakistan 3 0 28 Complex 72 6.5 F 0
1226c,d Iraq 1 0 20 Complex 56 1.4 M > 4
1229 Lebanon 18 0 19 Complex 52 2.3 M < 1 month
1231a,e China 2 0 32 Carbonate 100 (6 months) 1.7 F Unknown
NA, not applicable.
aNonpregnant controls. bGave birth to twins. cPregnant when recruited. dAbout 4 months pregnant on recruitment. eSubject 1231 returned to China immediately after giving birth.
Table 2. Product information.
Product 1 (complex product) Product 2
Calcium Calcium Calcium Calcium carbonate +
Composition citrate phosphate amino acid vitamin D3
Weight Ca compound (mg) 300 325 200 1,500
Equivalent Ca (mg) 64 126 40 600
Daily total Ca (mg) 920 1,200
Daily dosage 3 times after meals, 1 on retiring Twice daily
206Pb:204Pb 20.1 18.5
Pb [µg/kg (µg/tablet)] 293 (0.4) 940 (1.6)
Daily Pb intake (µg) 2.8 3.2Using a cohort of generally younger adults,
we showed that an extra intake of 900–1,000
mg calcium/day for 6 months had minimal
impact on the blood lead concentration
(Gulson et al. 2001). However, we observed
changes in the isotopic composition of the
blood with a calcium carbonate supplement
indicating that lead from the supplement was
entering blood, but at this stage we have no
explanation as to why there were no changes
in blood lead concentration.
Oral and written instructions regarding
dosage were given to the subjects. Compliance
relied largely on the loyalty established between
the cohort coordinator and the subjects to
accurately report compliance, and this was
checked monthly by tablet count.
A control group taking a placebo or not
taking calcium supplements was decided
against because, first, although investigated,
producing a placebo for such a small group of
subjects was not considered viable; second, the
much larger cohort in our previous pregnancy
investigations had very low calcium intakes,
and the present study was one outcome of
this; and third, ﬁnancial constraints given the
expense of running such a project.
Data treatment. After a visual inspection of
graphic presentations, we analyzed changes in
206Pb:204Pb (and 207Pb:206Pb) ratios and blood
lead concentration over time from the mini-
mum value of blood lead concentration before
an increase during late pregnancy using a
regression analysis for time series that took into
account any autocorrelation of the residuals
from the sequences of observations (the autore-
gression procedure in SPSS 11.0; Chicago, IL,
USA). The autocorrelation was taken into
account when calculating the signiﬁcance and
magnitude of time effects (Ostrom 1990).
To assess changes in 206Pb:204Pb (and
207Pb:206Pb) ratios and blood lead concentra-
tion between pregnancy and postpartum for
individual subjects, we used an interrupted
time-series analysis procedure (Crosbie 1995).
In this analysis, the intercept and slope of the
pregnancy (baseline) regression line are jointly
compared with those of the regression ﬁtted to
the postpartum (treatment) phase, and if the
joint test is signiﬁcant, differences between the
two intercepts and two slopes can be consid-
ered. This procedure takes account of autocor-
relation when ﬁtting the lines and testing the
differences, and provides better control of type
I error (i.e., an erroneous inference of a signiﬁ-
cant difference between phases/stages in exper-
iments) than does visual inspection and has
acceptable power. It requires measurements
at regular intervals, as exemplified by the
monthly blood sampling in our investigation.
We calculated the extra amount of lead
added to blood during pregnancy and post-
partum using a similar area under the curve
method that was used for our previous
cohort (Gulson et al. 1999). This compara-
tive graphic technique is commonly used
for cumulative estimates of lead exposure
by integrating blood lead concentration
across exposure times in occupational expo-
sure (Chia et al. 1996) or for comparative
lead dosings of test animals in the study of
such exposure parameters as the relative
bioavailability of lead (Casteel et al. 1997).
Estimates of extra lead flux mobilized were
possible only for migrant subjects whose
blood lead concentrations exhibited positive
variations during the monitoring period
(n = 10). We calculated the extra flux by
estimating the total area generated by serial
blood lead concentrations versus pregnancy
and postpregnancy time and subtracting the
estimated background area, the portion of
the area representing blood lead over time
that would have occurred in the absence of
added lead releases. Background area was
generated from the lowest blood lead level
during late pregnancy, in contrast to our
previous study (Gulson et al. 1998b), in
which the minimum blood lead level usually,
although not always, occurred in the first
trimester.
Results
Changes in blood lead during pregnancy and
6 months postpartum. The data for the present
case series have been subdivided into two
groups depending on the length of breast-
feeding: those who breast-fed for longer peri-
ods (Figure 1), in this case ≥ 3 months, and
those who breast-fed for shorter periods, either
not at all or for < 1 month (Figure 2).
To account for the well-recognized
changes in blood volume during pregnancy
(Hytten 1985), increases of which may result
in decreases in blood lead concentration, the
blood leads can be adjusted for changes in
hematocrit. Data for subjects 1212 and 1214
are shown in Figure 3, which illustrate the
changes in hematocrit and the hematocrit-
corrected and uncorrected blood lead con-
centrations over time. Hematocrit values
throughout pregnancy in the present case series
show decreases, little change, or decreases and
then increases in late pregnancy (0–2 months
before parturition). As shown in Figure 3, the
uncorrected and corrected blood lead values
follow similar trends and, because of the
“return-to-normal” hematocrit values during
the postpartum period and the importance of
this period for our results, measured blood
lead values are shown in the accompanying
ﬁgures.
Changes in blood lead during pregnancy
followed similar U-shaped patterns for the
two groups. From early to mid-pregnancy
the hematocrit-corrected blood lead concen-
trations decreased for 8 of the 10 subjects
and for the second pregnancy of subject
1208. During late pregnancy, the blood lead
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Figure 1. Changes in blood lead concentration (not
corrected for hematocrit) for subjects who breast-
fed for ≥ 3 months. The length of breast-feeding is
noted to the right of the individual lines. Increases
in blood lead concentration occurred in late preg-
nancy compared with our previous cohort (Gulson
et al. 1998b), whose calcium intakes were very low.
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Figure 2. Changes in blood lead concentration (not
corrected for hematocrit) for subjects who breast-
fed for ≤ 1 month. The length of breast-feeding is
noted to the right of the individual lines. Increases
in blood lead concentration occurred in late preg-
nancy compared with our previous cohort (Gulson
et al. 1998b), whose calcium intakes were very low.
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Figure 3. Plot illustrating the changes in hematocrit
values (HCt) and uncorrected (PbB) and hemat-
ocrit-corrected (HCt Corr) blood lead concentra-
tions for subjects 1212 and 1214. The U-shaped
pattern for blood lead concentrations over time
persists in the hematocrit-corrected values. The “0
days” scale is offset for subject 1212 and is
denoted for all subjects by the breaks in the lines.concentrations increased in all subjects
(Table 3); the increase in blood lead concen-
tration above a minimum value, corrected for
hematocrit, ranged from 10 to 55% (geomet-
ric mean, 25%), although the values did not
exceed those determined in prepregnancy or
early pregnancy.
Changes in blood lead from late preg-
nancy through the 6 months postpartum
were variable and did not appear to be related
to length of breast-feeding and calcium
intakes. The maximum value during postpar-
tum the concentration was almost double the
minimum blood lead value during late preg-
nancy in half the subjects; the percentage
increase varied from 30 to 95%. For half the
subjects (subjects 1204, 1211, 1213, and
1226), the blood lead increased until the sec-
ond or third month postpartum and then
either leveled or decreased (Figures 1 and 2).
Only in subjects 1212 and 1208 was there a
continuous linear increase from late pregnancy
through postpartum. The increases post-
partum in both groups commonly exceeded
the values measured in prepregnancy or early
pregnancy.
Autoregression analyses of blood lead con-
centration from the time of minimum value in
late pregnancy through postpartum for eight
subjects are presented in Table 4. There are
signiﬁcant positive increases for half the sub-
jects and none for the other four (subjects
1211, 1213, 1214, 1226). However, visual
inspection of the plots (Figures 1 and 2) shows
that for the latter four, there are increases from
late pregnancy to the ﬁrst 1 or 2 months post-
partum and, thereafter, either a leveling or
decrease in blood lead.
For the interrupted time-series analyses, the
overall test of change was signiﬁcant for ﬁve of
eight subjects in blood lead concentration dur-
ing the whole of the pregnancy phase com-
pared with the postpartum phase (Table 5).
There were signiﬁcant differences in the blood
lead slopes for half of the eight subjects during
pregnancy compared with postpartum, and for
six of eight subjects there were significant
differences in intercept.
Subject 1225 showed a major increase in
blood lead concentration soon after parturi-
tion, with the value increasing from 5.6 to
about 43 µg/dL. This increase was accompa-
nied by a large decrease in the 206Pb:204Pb
ratio toward Australian environmental values
(Figure 4).
The blood lead concentrations for the
controls showed only small variations and an
overall decrease over time (Figure 5).
As is well documented in the literature,
the cord blood lead concentrations were lower
than those of the last maternal sample taken
before parturition. The geometric mean ratio
of cord:maternal blood lead was 0.72, with a
range from 0.55 to 0.93, and the correlation
of cord versus maternal blood lead had an
r2 of 0.93.
Changes in isotopic ratios during pregnancy
and 6 months postpartum. As was the case for
blood lead concentrations, changes in isotopic
ratios varied but not with consistent trends
(Figures 6 and 7). In some subjects (1212,
1214, 1225, 1229) it was not possible to esti-
mate any changes in isotopic composition
during pregnancy, especially late pregnancy,
because of a change in the slope or scatter of
the data (Table 3). In the other subjects, any
changes during late pregnancy ranged from lit-
tle difference from the experimental error of
± 0.2% up to 0.8% for subject 1226.
Autoregression analyses for the 206Pb:204Pb
(and 207Pb:206Pb) ratio from the time of mini-
mum value in late pregnancy through post-
partum for eight subjects are presented in
Table 4. The analyses for both ratios give
consistent results, except for subject 1229,
although those for the 207Pb:206Pb ratio tend
to show better correlation than those for the
206Pb:204Pb ratio, probably because of the
higher precision and ease of measurement of
the 207Pb:206Pb ratio (~ 0.9) compared with
the larger 206Pb:204Pb ratio. Four of the eight
subjects who were monitored during the
6 postpartum months (1204, 1208, 1213,
1229) showed significant increases in the
206Pb:204Pb ratio, whereas there were minimal
changes for the other subjects.
For the interrupted time-series analyses, in
no case was there a significant overall test of
change for 206Pb:204Pb (and 207Pb:206Pb ratio;
not shown in Table 5), nor was there any sig-
niﬁcant difference in the slopes or intercepts
for the isotopic ratios (Table 5).
There were small variations in the isotopic
compositions of the control subjects (Figure 5).
The ratios for the Bulgarian subject decreased
slowly, reﬂecting an ongoing exchange between
her long-term body stores and Australian
environmental lead, as we have observed in
migrant subjects who did not conceive (Gulson
et al. 1997b).
Isotopic ratios in the cord blood samples
were similar to those in the maternal blood
samples taken before parturition (r2 = 0.98),
as we found in our previous studies (Gulson
et al. 1998b) and also observed by Manton
(1977, 1985). The similarity in isotopic ratios
of the maternal and cord blood samples pro-
vides confirmation of the placental transfer
of lead.
Dietary samples. Lead concentrations in
duplicate diet samples vary considerably both
between and within subjects. For example, the
geometric mean concentration for all subjects
was 7.1 µg/kg with a range of 3.0–20.1 µg/kg
(n = 48). In contrast, the range in 206Pb:204Pb
ratio was surprisingly less than expected, from
17.79 to 18.81, with a geometric mean ratio
of 18.25.
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Table 3. Changes during pregnancy and postpartum.
Percent increase in
Month PbB late pregnancy Percent increase Percent increase Extra
Country of increased PbB postpartum in PbB:min ﬂuxd
Identiﬁer origin > minimuma (HCt corr) 206Pb:204Pbb PbB 206Pb:204Pbb valuec (µg)
1204 Bulgaria 8 40 0.17 30 0.33 90 380
1208 Bosnia 8 55 0.11 40 1.22 95 150
1211 Bangladesh 6 10 0.51 50 ND 90 125
1212 Turkey 8 10 ND 55 ND 95 235
1213 Lebanon 8 25 0.28 30 1.65 70 140
1214 Turkey 8 40 ND 10 0.61 40 80
1225 Pakistan 6 50 ND NA NA NA NA
1226 Iraq 8 20 0.80 20 ND 50 200
1229 Lebanon 6 10 ND 40 0.2 30 50
1231 China 4 40 0.33 NS NS NA 165a
Abbreviations: (HCt corr), (hematocrit corrected); min, minimum; NA, not applicable; ND, not able to be estimated
because of change in slope (see ﬁgures); NS, no samples; PbB, blood lead concentration. 
aDuring pregnancy. bRelative to experimental error of ± 0.2%. cLate pregnancy to postpartum. dExtra lead released from
bone during late pregnancy and postpartum.
Table 4. Results for autoregression analyses.
R2-value p-Value
Subject 206Pb:204Pba 207Pb:206Pb PbB 206Pb:204Pb 207Pb:206Pb PbB
1204 0.87 (10) 0.91 0.63 (9) < 0.001 < 0.001 0.007
1208 0.94 (9) 0.94 0.85 (9) < 0.0001 < 0.00001 < 0.001
1211 0.12 (11) 0.25 0.22 (10) 0.32 0.15 0.38
1212 0.09 (9) 0.23 0.94 (8) 0.46 0.25 0.002
1213 0.91 (7) 0.85 0.40 (6) 0.006 0.01 0.30
1214 0.12 (10) 0.60 0.09 (9) 0.35 0.07 0.37
1226 0.04 (9) 0.16 0.14 (8) 0.56 0.31 0.45
1229 0.76 (8) 0.28 0.77 (7) 0.002 0.21 0.002
Numbers of data points in analysis are given in parentheses. 
aCord blood value incorporated in analysis, except for subject 1208 (no sample available).There does not appear to be any relation-
ship between calcium intake and changes in
isotopic composition of blood lead during
pregnancy and postpartum. For example, sub-
jects 1208 and 1213 exhibited the largest
increases in 206Pb:204Pb ratio and had a high
compliance with calcium supplements.
Likewise, subjects 1204 and 1212 had a high
compliance and showed large increases in
blood lead concentration postpartum. There
was also no relationship between the time of
increase in blood lead during pregnancy and
calcium intake.
Environmental samples. Dustfall accumu-
lation ranged from 6 to 94 µg/m2/month
with a geometric mean of 17 µg/m2/month
(n = 36). The 206Pb:204Pb ratios ranged from
16.50 to 17.85 and were similar to values
measured in Sydney air from high-volume air
ﬁlter samples (Chiaradia et al. 1997); the geo-
metric mean was 17.16.
Lead concentration in fully ﬂushed drink-
ing water ranged from 0.03 to 1.1 µg/dL with
a geometric mean 206Pb:204Pb ratio of 16.80;
at these very low concentrations, water has no
impact on blood lead.
Discussion
Changes in blood lead concentration and iso-
topic ratios during pregnancy and 6 months
postpartum. Mean increases of approximately
25% in blood lead concentration during late
pregnancy for our present case series with
calcium supplementation are consistent with
increases observed in our previous cohort
(Gulson et al. 1998b) with low calcium intakes
and in several other studies (Hertz-Picciotto
et al. 2000; Lagerkvist et al. 1996; Rothenberg
et al. 1994; Schell et al. 2000, 2003;
Schumacher et al. 1996; Sowers et al. 2002;
West et al. 1994). However, the increases
found in the present study occurred later in
pregnancy than in our previous cohort
(Gulson et al. 1998b) and in many of the
other studies (Hertz-Picciotto et al. 2000;
Lagerkvist et al. 1996; Rothenberg et al. 1994;
Schell et al. 2000, 2003; Schumacher et al.
1996; Sowers et al. 2002; West et al. 1994).
The changes in blood lead during the
whole of pregnancy follow a U-shaped curve,
as previously observed by Rothenberg et al.
(1994), Hertz-Picciotto et al. (2000), Sowers
et al. (2002), and Schell et al. (2000, 2003).
Apart from the recent study of Manton et al.
(2003) and our investigations (Gulson et al.
1995, 1997a, 1998b), only limited numbers
of samples were collected in the other studies,
usually a maximum of one for each trimester,
one at delivery, and one postpartum. In our
present case series, the changes in blood lead
during pregnancy were obvious whether the
blood lead values were corrected or uncor-
rected for hematocrit. Hematocrit-corrected
values did not alter the findings of Hertz-
Picciotto et al. (2000) and Schell et al.
(2000), but in the case of Schumacher et al.
(1996), the decrease in uncorrected blood
lead in the first trimester compared with
prepregnancy was not observed for the
hematocrit-corrected values. Furthermore,
blood lead values in the second trimester
(~ 20 weeks) showed average increases of
approximately 14%, and for the maximum
increase observed in the 32-week sampling,
the change from the minimum value at
8 weeks was 36%. Sowers et al. (2002)
observed increases in blood lead from the
20th week to delivery in African Americans
(1.20–1.49 µg/dL; an increase of 24%) and
Hispanic Americans (0.99–1.32 µg/dL; an
increase of 33%) but a barely detectable
decrease in blood lead of 0.03 µg/dL at
delivery for Caucasians. Schell et al. (2003)
observed smaller increases in blood lead from
the second trimester to delivery in whites
(1.6–1.8 µg/dL; an increase of 12%) com-
pared with African Americans (1.8–2.5 µg/dL;
an increase of 39%).
Four of the eight subjects in the present
case series showed linear increases in blood
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Table 5. Results for interrupted time-series analyses.
No. of measures Sum squares intercept Sum squares slope Overall test of change
Subject Pregnancy PP t-Value p-Value t-Value p-Value F-value p-Value
1204 7 7 1.40 0.194 0.45 0.664 0.14 (2,9) 0.87
8 6 4.12 0.003 –3.14 0.012 5.75 (2,9) 0.025
1208 7 6 0.52 0.617 1.41 0.197 1.16 (2,8) 0.36
7 6 4.79 0.001 –3.35 0.010 5.81 (2,8) 0.028
1211 8 7 –1.94 0.081 1.41 0.188 1.28 (2,10) 0.32
8 6 2.50 0.034 –2.15 0.06 4.91 (2,9) 0.036
1212 9 7 2.03 0.068 –1.45 0.175 2.01 (2,11) 0.181
9 6 2.70 0.022 –1.21 0.255 0.83 (2,10) 0.464
1213 9 5 –0.11 0.915 1.39 0.197 1.50 (2,9) 0.274
9 4 4.77 0.001 –4.0 0.004 8.01 (2,8) 0.012
1214 10 7 1.23 0.241 0.22 0.828 3.60 (2,12) 0.060
10 6 –1.21 0.253 1.04 0.320 0.64 (2,11) 0.547
1226 6 8 1.57 0.15 –1.02 0.34 1.05 (2,9) 0.39
6 7 3.94 0.004 –4.39 0.002 10.27(2,8) 0.006
1229 8 5 –0.05 0.964 1.11 0.301 1.09 (2,8) 0.380
8 4 1.32 0.229 –0.76 0.474 1.10 (2,7) 0.385
PP, postpartum. For all subjects, first row is 206Pb:204Pb and second row is PbB. Values in parentheses are degrees of
freedom. Cord blood value incorporated in postpartum analysis, except for subject 1208 (no sample available).
Figure 4. Plot of blood lead concentration (PbB)
and isotopic ratios for subject 1225, who experi-
enced a major unknown lead exposure soon after
parturition (Part).
Figure 5. Plot of blood lead concentration (PbB) and
isotopic ratios for subjects 1207 and 1224, who acted
as nonpregnant controls.
Figure 6. Changes in isotopic ratio expressed as
206Pb:204Pb for subjects who breast-fed for ≥3 months.
The length of breast-feeding is noted to the right of
the individual lines.
Figure 7. Changes in isotopic ratio expressed as
206Pb:204Pb for subjects who breast-fed for ≤1 month.
The length of breast-feeding is noted to the right of
the individual lines.lead concentration from the minimum in
late pregnancy through postpartum, but there
was no consistency with length of breast-
feeding or compliance with calcium supple-
mentation. Manton et al. (2003) also found
major increases in blood lead concentration by
up to a factor of 3 from a minimum value dur-
ing pregnancy to postpartum. The magnitude
of the increases was attributed partly to breast-
or bottle-feeding by the mothers. In contrast
to the changes observed in the above investi-
gations, Berglund et al. (2000) could not
detect any increase in blood lead during preg-
nancy, but they found a signiﬁcant increase in
blood lead concentration during lactation.
Extra blood lead and calcium supple-
mentation. For our present case series, with
subjects taking calcium supplements, the
increases in blood lead from the minimum
value during late pregnancy took place at
about 6–8 months in all subjects. In con-
trast, for the previous cohort (Gulson et al.
1998b), whose daily calcium intake was
generally very low, an increase in blood lead
from the minimum occurred at 3–4 months
for six of the nine subjects. Thus, even
though there is an increase of similar magni-
tude in blood lead from a minimum value
during pregnancy in both these cohorts, the
fetus in the group receiving calcium supple-
ments would be exposed to considerably
lower lead flux than would those whose
mothers had a low calcium intake. This is
confirmed by the lower mean value of
145 µg lead for the extra flux to blood dur-
ing late pregnancy through postpartum for
the present higher-calcium-intake subjects
compared with the mean of 330 µg lead for
the low-calcium-intake cohort. In breast-
feeding mothers who were consuming close
to, or exceeding, what they recommended as
the daily calcium intake of 1,000 mg/day,
Manton et al. (2003) suggested there was no
tendency for increases in blood lead in late
pregnancy. However, inspection of their
Figure 2 shows that there are increases in
blood lead concentration in the last
2 months of pregnancy; increases in blood
lead in late pregnancy also occurred for at
least four bottle-feeding mothers with vary-
ing calcium intakes, consistent with our
observations.
We argued that the changes in blood lead
concentration and isotopic composition dur-
ing pregnancy and postpartum in our previ-
ous cohort (Gulson et al. 1998b) reflected
increased mobilization of lead from the
maternal skeleton, probably associated with
the low calcium intakes of the subjects
(Gulson et al. 1998b). Any changes in blood
lead concentration during pregnancy and
postpartum are a function of plasma volume,
red cell mass, and variations in lead ﬂux from
endogenous and exogenous sources. Low
blood lead concentrations during the ﬁrst half
of pregnancy have been attributed to hemo-
dilution (Rothenberg et al. 1994), which has
been associated mainly with an increased
plasma volume, calculated by Hytten (1985)
to be approximately 1,250 mL for a normal
pregnancy. Hytten (1985) showed that once
the “plateau” of increased plasma volume had
been attained at about week 30 of pregnancy,
there was minimal increase in plasma volume
and, as expected, little change during postpar-
tum. That is, the dilution effects of increased
plasma volume on blood lead concentration
should be most marked during the second
and early third trimesters. Hytten (1985) also
drew attention to changes in red cell mass and
the impact of iron supplementation on this.
The changes in volume are mirrored in hema-
tocrit, which decreases until third trimester
and then increases above normal values until
early in postpartum (Figure 3; also see Schell
et al. 2000, their Figure 2). During preg-
nancy, if the ﬂux of lead into blood remains
constant, blood lead concentration will
decrease as blood volume increases. On the
other hand, if blood lead concentrations
remain constant or increase during late preg-
nancy, this suggests that there has been an
increase in lead ﬂux into the blood.
The decreases in blood lead from early to
mid-pregnancy in our present and previous
cohort (Gulson et al. 1998b) are consistent
with a hypothesis of reduced flux from the
skeleton, as indicated by our estimations of
ﬂux. Such a reduction in lead ﬂux was noted by
Franklin et al. (1997) in cynomolgus monkeys
and in one subject in the recent study of
Manton et al. (2003). Although they did not
report data from early pregnancy, Manton et al.
(2003) hypothesized that in early (to mid) preg-
nancy, only trabecular bone of presumably low
lead content was resorbed, decreasing lead con-
centrations more than expected from hemo-
dilution alone. In late pregnancy, more cortical
bone with a presumed higher lead content was
resorbed, increasing blood lead concentrations.
Such a hypothesis would appear to conﬂict with
measurements of bone lead over the past
decades showing that patella or calcaneus (tra-
becular) bone has higher concentrations than
does tibia (cortical) bone (e.g., Hernandez-Avila
et al. 2002; Oliveira et al. 2002; Rothenberg
et al. 2000) and that the trabecular/cortical bone
lead ratio ranges from 1 to 2. Nevertheless, the
total body burden of lead in cortical bone is
generally higher than in trabecular bone
because the proportion of cortical:trabecular
bone is about 4:1.
Bone research of relevance to the changes
in lead during pregnancy and lactation. The
linear increases in blood lead isotopic ratio,
blood lead concentration, and increased lead
ﬂux to blood during late pregnancy and post-
partum in half the subjects from the present
case series and most subjects in our previous
cohort (Gulson et al. 1998b) are attributed to
increased flux from the maternal skeleton,
despite increased calcium intake for the pre-
sent case series.
Rather than cortical bone providing the
major contribution to increased blood lead, as
suggested by Manton et al. (2003), it may
well be trabecular bone. For example, based
on bone X-ray fluorescence measurements,
Schütz et al. (1987) and Hu et al. (1989) sug-
gested that trabecular bone exerted the most
inﬂuence on blood lead and that this was con-
sistent with the higher vascular and turnover
rates associated with trabecular compared
with cortical bone.
Bone mineral density and biochemical
markers of bone turnover and especially resorp-
tion during pregnancy and lactation appear
to affect trabecular more than cortical bone
(Black et al. 2000; Kolthoff et al. 1998; Naylor
et al. 2000; Sowers et al. 2000) as a result of
having more cancellous (trabecular) bone
surfaces available for turnover (Sowers et al.
2000). Even though Sowers et al. (2000) stated
that ﬁndings of previous studies were inconsis-
tent, there was a convergence toward bone loss
during pregnancy and lactation. For example,
there are ﬁndings of increase at localized bone
sites (Drinkwater and Chestnut 1991), no
change (Sowers et al. 1991), and bone loss
(Aguado et al. 1998; Honda et al. 1998;
Kolthoff et al. 1998; Lamke et al. 1977; Laskey
et al. 1998; Naylor et al. 2000; Pires et al.
2002; Ritchie et al. 1998; Sowers et al. 1995).
Lactation would appear to be associated with a
larger decrease in bone density and net bone
loss of from 1 to 5% during 3–6 months post-
partum compared with pregnancy (Laskey
et al. 1998; Pires et al. 2002; Ritchie et al.
1998; Sowers et al. 1995).
Bone research can provide further useful
information with respect to the observation in
lead pregnancy studies that the most signifi-
cant increase in blood lead concentration (and
signiﬁcant changes in isotopic ratios) occurs in
late pregnancy. For example, Sowers et al.
(2000) confirmed that there was increased
bone turnover in the third trimester of preg-
nancy compared with the first trimester, as
determined by measurement of the urinary
excretion of markers of type I collagen, but
suggested that the mechanisms of bone resorp-
tion during pregnancy are poorly understood.
Furthermore, the data of Black et al. (2000)
and Naylor et al. (2000) indicated that there
was a dissociation of bone formation and
resorption in the ﬁrst two trimesters and well
into the third trimester of pregnancy. They
suggested that the gain in bone mineral den-
sity at cortical bone sites during pregnancy
may result from the redistribution of mineral
from trabecular to cortical bone sites and that
elevated bone turnover may explain trabecular
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hand, a study of primates using the stable lead
isotope method indicated that there was a
reduction in ﬁrst-trimester bone mobilization
(Franklin et al. 1997). These conclusions are,
however, inconsistent with data from bone
mineral density and bone turnover indices
demonstrating that bone resorption increased
in the first trimester. For example, the bone
biopsy data of Purdie et al. (1988) in women
at the time of termination of pregnancy at
12–14 weeks of gestation showed that bone
resorption predominated in early pregnancy.
Likewise, Shahtaheri et al. (1999) reported
early bone loss in bone biopsy samples from
15 women in their ﬁrst trimesters, whereas at
term in another 13 women they found new
and more numerous (but thinner) trabeculae.
Bone turnover and calcium and lead rela-
tionships during pregnancy and lactation.
Changes in blood lead during pregnancy and
lactation are inexorably linked with changes
in calcium. During pregnancy and lactation,
there is increased demand for calcium for
transport to the fetus. The maternal response
to the demand for calcium theoretically can
involve increased absorption of calcium from
the intestine, greater calcium conservation by
the kidneys, or greater bone turnover (Sowers
et al. 2000). There are, however, wide dispari-
ties in the literature on both bone/calcium
and lead about the efﬁcacy of calcium intakes
during pregnancy and lactation.
Several authors consider that bone mine-
ral changes especially during lactation are hor-
monally regulated and independent of
the amount of calcium in the woman’s diet;
provision of additional calcium has minimal
impact on preventing bone resorption at sites
such as the spine and femur (Cross et al.
1995; Kalkwarf 1999; Kolthoff et al. 1998;
Laskey et al. 1998; Prentice 2000). For exam-
ple, Prentice (2000) states there are ﬁrm data
demonstrating that a low calcium intake
during lactation does not lead to impaired
lactational performance or to exaggerated
bone loss.
In contrast, previous evidence suggested
that bone loss during lactation in adolescents
may be prevented by adequate dietary cal-
cium intakes (Chan et al. 1987). Later on,
Krebs et al. (1997) suggested that bone loss
during lactation may be attenuated by a
generous dietary ratio of calcium to protein.
Specker et al. (1994) concluded that even
when dietary intake of calcium exceeded
the recommended daily intake, the calcium
demands in lactation in humans were prefer-
entially met by increased skeletal resorption of
calcium and probably increased renal con-
servation of calcium, but not by increased
intestinal absorption of calcium.
Like the complexity in the bone/calcium
literature, the relationships between bone lead,
calcium, bone turnover, and reproduction are
also controversial. For example, Rothenberg
et al. (2000) found calcaneus and tibia lead
were directly associated with prenatal third
trimester blood lead but only calcaneus lead
was associated with postnatal blood lead. They
also found that there was no effect of dietary
calcium on calcaneus lead despite the more
easily mobilized trabecular lead. In a cross-
sectional Mexico City study, Hernandez-Avila
et al. (1996) also found a significant asso-
ciation between trabecular bone lead (in the
patella) and postnatal blood lead and a signiﬁ-
cant effect of calcium on patella lead.
With respect to calcium intakes, several
studies have suggested that dietary calcium
may have a protective role against lead by
decreasing absorption of lead in the gastro-
intestinal tract and by decreasing the mobili-
zation of lead from bone stores to blood,
especially during periods of high metabolic
activity of the bone such as pregnancy, lacta-
tion, and menopause (e.g., Farias et al. 1996;
Hernandez-Avila et al. 1996, 1997, 2003;
Hertz-Picciotto et al. 2000). However, most
of these studies were cross-sectional in nature,
and dietary calcium was estimated by ques-
tionnaire, diary, or recall. Furthermore, the
outcomes between studies of similar popula-
tion groups were sometimes conﬂicting (e.g.,
Farias et al. 1996; Hernandez-Avila et al.
1996). In more recent studies in Mexico City,
calcium carbonate supplementation of
1,200 mg elemental calcium per day gave a
modest reduction of 16% in blood lead levels
among lactating women with relatively high
bone lead burden (Hernandez-Avila et al.
2003). In an earlier report apparently using
the same cohort but with lower numbers, there
did not seem to be any beneﬁt from calcium
supplementation (Tellez-Rojo et al. 2002).
Using a sensitive biomarker of bone resorp-
tion, levels of cross-linked N-telopeptides of
type I collagen (NTx), Janakiraman et al.
(2003) observed that a bedtime 1,200 mg cal-
cium supplement during the third trimester of
pregnancy reduced maternal bone resorption
by an average of 14%.
Contribution to blood lead from diet and
calcium supplements. In contrast to our previ-
ous cohort (Gulson et al. 1998b), where the
environmental and dietary contributions to
blood lead were considered minimal, condi-
tions were somewhat different in the present
case series. For example, even though the
206Pb:204Pb ratios in the dust, air, and water
are still lower than observed in the blood of
our migrant subjects and would contribute
little to blood lead, the ratios in the 6-day
duplicate diet increased considerably, espe-
cially since our market basket surveys of 1990
when the 206Pb:204Pb ratio was about 17.0
(Gulson et al. 1996). This change has come
about with globalization, especially of the
food supply. Nevertheless, we do not attribute
the increase in blood lead during the last
2 months of pregnancy to diet; otherwise,
there should have been obvious effects ear-
lier in the pregnancy. A potential source of
the increased lead may come from the cal-
cium supplements. These contribute almost
50% of the daily lead intake, and even
though we observed minimal changes in the
6-month trial of a separate cohort taking
the same dose and same type of calcium
supplements (Gulson et al. 2001), physio-
logic processes during pregnancy may affect
the uptake of lead even in the presence of
sufficient calcium. For example, pregnant
swine absorb and retain more lead than do
nonpregnant swine (Casteel et al. 2001),
and there is convincing evidence especially
from stable calcium isotope studies, men-
tioned above, that there is increased intesti-
nal absorption of calcium during pregnancy.
An increased absorption of lead from the
calcium supplement could partially explain
the increase in 206Pb:204Pb ratio observed
for three subjects during 6 months post-
partum, but there was no such change in
the other three subjects for whom we have
data. Furthermore, there was no consistency
in changes relating to the two different
supplements.
The major decrease in 206Pb:204Pb ratio
and increase in blood lead for subject 1225
postpartum are remarkable (Figure 4).
Fortunately, this subject was not breast-
feeding. A sample of the husband’s blood was
collected approximately 4 months after detec-
tion of the changes in his wife; it had a lead
concentration of 23 µg/dL and a 206Pb:204Pb
ratio of 16.62, consistent with an exposure
similar to that of the wife. Considerable effort
was devoted to determine the source of the
changes because they indicate a very high
acute dose of lead of Australian origin.
However, evaluation of the potential sources
(diet, traditional medicines, cosmetics, social
calendar) indicated that the only explanation
for the changes could be attributed to their
attendance at an ethnic fair where they
consumed foodstuffs different from their
regular diet.
In summary, despite the recent studies of
Hernandez-Avila et al. (2003) and Janakiraman
et al. (2003) pointing to beneﬁts from calcium
supplementation during pregnancy and lacta-
tion, signiﬁcant increases in blood lead during
late pregnancy and postpartum found in our
investigations and those of several other
authors appear to indicate that calcium supple-
mentation is ineffective in minimizing the
mobilization of lead from the skeleton during
lactation—a position consistent with evidence
from the calcium literature using bone density
and bone turnover index measurements
(Prentice 2003). It does appear to offer some
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protection, however, during pregnancy by
delaying the extra lead mobilized from bone
and reducing the extra ﬂux. Despite the poten-
tial exposure of the infant to lead from breast-
feeding, we have shown that the transfer of
lead to the infant from breast milk is low, espe-
cially at low blood lead concentrations (Gulson
et al. 1998a).
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